Vyant Bio, Inc.
VYNT · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,259 | -$3,463 | -$5,805 | -$9,163 |
| Dep. & Amort. | $198 | $198 | $207 | $240 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $321 | $305 | $282 | $278 |
| Change in WC | $60 | $657 | -$203 | $377 |
| Other Non-Cash | $388 | $49 | $1,356 | $4,296 |
| Operating Cash Flow | -$3,292 | -$2,254 | -$4,163 | -$3,972 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9 | -$247 | -$331 | -$30 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $3,956 | -$4 | -$42 | -$30 |
| Investing Cash Flow | $3,947 | -$251 | -$373 | -$60 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$188 | $0 | $0 | -$97 |
| Stock Repurch. | $58 | $0 | -$149 | -$97 |
| Dividends Paid | $0 | $0 | $0 | -$97 |
| Other Fin. Act. | -$8 | $197 | -$202 | -$34 |
| Financing Cash Flow | -$8 | $197 | -$202 | -$136 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $647 | -$2,308 | -$4,738 | -$4,168 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,394 | $11,702 | $16,440 | $20,608 |
| End Cash | $10,041 | $9,394 | $11,702 | $16,440 |
| Free Cash Flow | -$3,301 | -$2,501 | -$4,494 | -$4,002 |